Poor expression levels, solubilization, and stability — these are the daily challenges that your membrane protein production team faces every day. You go through long cycles of expression optimization with methods that often don’t provide all the information to decide which conditions to move forward with. The result is delayed projects and frustrated downstream teams or clients that expect timely delivery of high-quality membrane proteins.
Introducing Andromeda
Andromeda disrupts this status quo by providing increased efficiency to CROs and Biopharma membrane protein production teams by helping them optimize expression conditions with insights into both expression levels and thermal stability from a single assay in crude lysates.
Join us for an up-close tour of Andromeda to learn:
- How the current state of membrane protein expression impacts the efficiency of biopharma and CROs’ protein production teams
- How Andromeda increases your efficiency by giving you insights into both expression levels and thermal stability from a single assay in crude lysates
- How Andromeda works: Join a virtual tour that will give you a taste for sample loading, a run setup, and what the data output looks like
